Hill Alexandra E, Son Eric T, Paul-Heng Moumita, Wang Chuanmin, Ratnaseelan Shivanjali, Denkova Martina, Faridi Pouya, Braun Asolina, Purcell Anthony W, Mifsud Nicole A, Sharland Alexandra F
Transplantation Immunobiology Group, Sydney Medical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia.
Department of Biochemistry and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.
Front Transplant. 2025 Jan 29;4:1525003. doi: 10.3389/frtra.2025.1525003. eCollection 2025.
Mass Spectrometry allied with generation of activated alloreactive T cell populations and tetramer screening facilitates the identification of endogenous peptides that are directly recognised in complex with allogeneic Major Histocompatibility class I (MHC I) molecules by alloreactive CD8 T cells. We had previously used this approach for the discovery of immunogenic self-peptides presented by the allomorph H-2K (K). In this study, we identified 22 highly immunogenic self-peptides presented by H-2K (K). Peptide abundance across skin, spleen and liver samples (estimated as the product of the spectral intensity obtained for these samples) was the principal factor influencing recognition of peptide-K epitopes. Predicted binding affinity (BA score) and overall peptide hydrophobicity were also independently correlated with immunogenicity, while there was no significant correlation between the IEDB immunogenicity score and the proportion of T cells recognising a given epitope. Eight peptide-K epitopes were selected for inclusion in a tetramer panel to detect directly alloreactive CD8 T cells. This panel bound over 30% of activated alloreactive CD8 T cells after a prime-boost against K. Moreover, the panel identified alloreactive CD8 T cells within the graft infiltrate, spleen and draining lymph node during rejection of a K-bearing heart graft. In conclusion, small animal studies have demonstrated the feasibility of high-throughput approaches for the discovery of pMHC epitopes recognised by directly alloreactive T cells. Translating this approach to the human setting is achievable and will yield both critical insights into the fundamental basis of alloreactivity and powerful tools for immune monitoring in transplantation.
质谱联用激活的同种异体反应性T细胞群体的生成和四聚体筛选,有助于鉴定内源性肽段,这些肽段可被同种异体反应性CD8 T细胞直接识别为与同种异体主要组织相容性复合体I类(MHC I)分子形成复合物。我们之前曾使用这种方法来发现由同种异型H-2K(K)呈递的免疫原性自身肽段。在本研究中,我们鉴定出了22种由H-2K(K)呈递的高度免疫原性自身肽段。皮肤、脾脏和肝脏样本中的肽段丰度(估计为这些样本获得的光谱强度的乘积)是影响肽-K表位识别的主要因素。预测的结合亲和力(BA评分)和整体肽段疏水性也与免疫原性独立相关,而免疫表位数据库(IEDB)免疫原性评分与识别给定表位的T细胞比例之间没有显著相关性。选择了8个肽-K表位纳入四聚体库,以直接检测同种异体反应性CD8 T细胞。在针对K进行初次免疫-加强免疫后,该库与超过30%的激活的同种异体反应性CD8 T细胞结合。此外,在带有K的心脏移植物排斥反应期间,该库在移植物浸润、脾脏和引流淋巴结中鉴定出了同种异体反应性CD8 T细胞。总之,小动物研究已经证明了高通量方法用于发现直接被同种异体反应性T细胞识别的肽-MHC表位的可行性。将这种方法转化应用于人类是可行的,并且将为同种异体反应性的基本基础带来关键见解,同时为移植中的免疫监测提供强大工具。